What You Should Know:
– Withings, a global leader in connected health, has announced that its Sleep Rx sleep apnea device has received clearance from the U.S. Food and Drug Administration (FDA).
– Sleep Rx represents a significant advancement in the diagnosis of sleep apnea, offering a more convenient and accurate alternative to traditional in-lab testing.
Addressing the Underdiagnosis of Sleep Apnea
Sleep apnea is a serious condition that affects millions of people worldwide. However, it is often underdiagnosed due to the limitations of traditional diagnostic methods. Sleep Rx offers a scalable and accurate solution for home sleep apnea testing.
Key Features & Benefits of Sleep Rx
- Non-intrusive: Sleep Rx is a comfortable and unobtrusive device that fits under any mattress.
- Comprehensive Analysis: Provides detailed analysis of sleep, breathing, and cardiovascular activity.
- Accurate Diagnosis: Clinically validated for the diagnosis of sleep apnea.
- Easy to Use: Requires minimal setup and provides clear, easy-to-understand results.
- Improved Diagnosis: Sleep Rx can help to accurately diagnose sleep apnea, even in cases where traditional methods have failed.
- Increased Access: By offering a home-based testing solution, Sleep Rx can improve access to sleep apnea diagnosis.
- Improved Patient Outcomes: Early diagnosis and treatment of sleep apnea can lead to better health outcomes.
“We’re thrilled to bring Sleep Rx to the U.S. market,” said Antoine Robiliard, VP of Withings Health Solutions. “Enabling earlier and more precise diagnosis, Sleep Rx creates a new sleep apnea diagnosis and management paradigm. We know that a one-night assessment is not sufficient. By enabling more efficient and lower-cost home-based OSA diagnosis, Sleep Rx could not only reduce the staggering $150 billion annual economic burden of undiagnosed sleep apnea but also significantly improve long-term health outcomes.”
